Brief: Olix Pharmaceuticals Subsidiary mCureX Strengthens Scientific Advisory Board With Appointment Of Nucleic Acid Therapeutics And Immunology Specialist Dr. Gunther Hartmann
30/11/2021 14:27
Nov 30 (Reuters) - OliX Pharmaceuticals Inc 226950.KQ :
* OLIX PHARMACEUTICALS SUBSIDIARY MCUREX STRENGTHENS
SCIENTIFIC
ADVISORY BOARD WITH APPOINTMENT OF NUCLEIC ACID THERAPEUTICS AND
IMMUNOLOGY SPECIALIST DR. GUNTHER HARTMANN
Source text for Eikon: ID:nGNXwPvnN
Further company coverage: 226950.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug
Brief: OliX Pharmaceuticals Administers First Patient In Phase 1 Clinical Study of Androgenic Alopecia Treatment